A comprehensive 2026 guide to UK online casinos with a 400% bonus. Understand wagering, find the best offers, and see if a 4x match is actually worth it. Read our full guide to 400% casino bonuses
TruMerit and Credivera Issue First Verifiable Digital Credentials for Global Healthcare Professionals
TruMerit, a global leader in healthcare workforce development and credential verification, today announced that it has issued its first verifiable digital credentials to healthcare professionals through a new partnership with…
Holista Executes Binding JV for Collie Collagen Facility
Holista Colltech Limited (ASX: HCT) (Holista or the Company) is pleased to announce that it has entered into a binding Joint Venture Agreement with Swang Chai Chuan Limited (HKEX: 2321)…
Global Experts call for Paradigm Shift in Medicine, Health and Education to Save Lives and Fight Escalating Health Crisis
A global consortium of 64 experts (72 entities, 5 continents) unveiled two coordinated consensus plus policy brief reports, outlining a science‑driven roadmap to confront escalating health crises and to tackle…
CMS (867.HK/8A8.SG) Signed An Exclusive Commercialization and Supply Agreement for Marketed Originator Intravenous Iron Products Monofer(R) and Cosmofer(R)
China Medical System Holdings Limited (CMS or the Group) is pleased to announce that, the Group through its wholly-owned subsidiary entered into an exclusive commercialization and supply agreement (the Agreement)…
CMS (867.HK; 8A8.SG): NDA for the Seasonal Allergic Rhinitis Indication of Class 1 Innovative Drug MG-K10 Accepted in China
China Medical System Holdings Limited (the Group or CMS) is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Allergic Rhinitis (SAR) indication of MG-K10…
OBI Pharma Announces Ten Poster Presentations at the AACR 2026 Annual Meeting for GlycOBI(R) Glycan-based Site-Specific Antibody-Drug Conjugates (ADCs): Mono and Bi-Specific (inc. Dual payload) and Obrion(TM) ADC enabling technologies
Poster Presentations featuring the latest advancements on anti-TROP2 (OBI 902) and Nectin-4 (OBI 904) ADCs, anti-TROP2/HER2 BsADC (OBI 201), anti-cMET/HER3Bs-Dual Payload ADC (OBI 221),and OBI’s novel Obrion(TM) ADC enabling technologies(GlycOBI(R)…
Wellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient Lives
Joint venture executed combining Wellgistics Hub and KareRx Hub technology and operations Integrated platform accelerates pharmaceutical access, fulfillment, and commercialization Combined ecosystem provides potential reach to an estimated 200,000+ patient…
Avantor India Expands its Strategic Collaboration with Parafilm to Serve the Indian Laboratory Consumables Market
Avantor, Inc., a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries, announced that Avantor India has been…
Guoyuan International: Essex Bio-Technology Embarks on Global Expansion, Maintains BUY Rating with Target Price of HK$6.84
Guoyuan International issued a research report on Essex Bio-Technology on 1 April 2026. Essex posted steady operating performance growth in 2025 and kicked off its international expansion, as the Phase…
Formerra Announces Global Price Increase
Formerra, a leading distributor of performance materials, today announced a global price increase of $0.02 / lb on all products. The increase addresses higher operating costs related to rising material…
Dialogue with HighTide Therapeutics’ CMO Dr. Filip Surmont: Moving Beyond the “Blockbuster” Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach
Across the landscape of global biotech companies, the appointment of a senior executive often serves as a “barometer”—offering insights into a company’s pipeline potential and reflecting how industry veterans gauge…
A Closer Look at Fosun International 2025 Annual Results: ‘One-Off Risk Clearance’ Paves Way for ‘RMB10 Billion Profit’
On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group’s total revenue reached RMB173.43 billion, and adjusted industrial operation profit was…
CanSinoBIO: From Profit Turnaround to Value Realization as an Innovative Vaccine Leader
China’s 2026 Report on the Work of the Government identified biopharmaceuticals as an emerging pillar industry, underscoring a supportive policy environment for innovative drugmakers. In this context, CanSino Biologics Inc.…
Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce
TruMerit-led report highlights innovative staffing models, technology-enabled care, and team-based approaches to strengthen health systems worldwide. A new international report released today by TruMerit™ calls for a fundamental redesign of…
Ausnutria 2025 Annual Results: Revenue Powered by International Business and Family Nutrition, Lean Management Underpins Operational Resilience
On 27 March, Ausnutria Dairy Corporation Ltd (Stock Code: 1717.HK, hereinafter referred to as Ausnutria or the Company) officially released its 2025 annual results announcement. According to the announcement, Ausnutria…
Modern Dental Group Announces 2025 Annual Results, Net Profit Surges 47.7% on Digitalization-Driven Operational Efficiency Gains
RESULTS HIGHLIGHTS: – The Revenue for the year ended 31 December 2025 was approximately HK$3,736.5 million, representing an increase of approximately 11.1% as compared with the same period last year.…
Hua Medicine Announces 2025 Annual Results
– Annual sales of HuaTangNing exceeded 4 million packs, a year-on-year increase of 91%, with revenues reaching RMB 492.9 million, a year-on-year increase of 93%, marking outstanding results from the…
Sino Biopharm (1177.HK) Announces 2025 Annual Results
– Innovation and R&D Advance Steadily, RMB 31.83 Billion in Revenue Recorded – Underlying Profit Attributable to Owners of the Parent of RMB 4.54 Billion Recorded Development Highlights – During…
Formerra Announces Transportation Surcharge to Address Ongoing Freight and Logistics Market Pressures
Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across the Americas freight and logistics market. Beginning April 1, 2026,…
Hengrui Pharma Announces Strong 2025 Annual Results
On March 25, 2026, Hengrui Pharma (600276.SH; 01276.HK) announced robust financial results for the full year 2025, fueled by its dual strategy of innovation and globalization. Revenue increased 13.02% year-on-year…